United States · FDA National Drug Code directory
HAEGARDA C1 Esterase Inhibitor Subcutaneous (Human)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63833-829_c53fd34d-f366-4ee5-bbea-88201bf6b7c8
- Product NDC
- 63833-829
- Form
- KIT
- Composition / generic term
- HUMAN C1-ESTERASE INHIBITOR
- Labeler
- CSL Behring GmbH
- Marketing category
- BLA
- Marketing start / end (source format)
- 20170622
- Source listing expiry
- 20261231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (63833-829-02) * 5.6 mL in 1 VIAL, SINGLE-USE (63833-839-01) * 5.6 mL in 1 VIAL, SINGLE-USE (63833-765-19) · 63833-829-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →